Global Blood Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Global Blood Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Global Blood Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Global Blood Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Global Blood Therapeutics Inc is developing drugs for the treatment of hypoxia and idiopathic pulmonary fibrosis. The company is headquartered in South San Francisco, California, the US.
Headquarters
United States of America
Address
181 Oyster Point Boulevard, San Francisco, California, 94080
No of Employees
457
Industry
Pharmaceuticals and Healthcare
Revenue (2021)
$194.7M
Global Blood Therapeutics Inc premium industry data and analytics
Competitor Comparison
| Key Parameters | Global Blood Therapeutics Inc | Bristol-Myers Squibb Co | Emmaus Medical Inc | Medunik USA Inc | Novartis Pharmaceuticals Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | San Francisco | Princeton | Torrance | Princeton | East Hanover |
| State/Province | California | New Jersey | California | Pennsylvania | New Jersey |
| No. of Employees | 457 | 34,100 | - | - | - |
| Entity Type | Private | Public | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer